Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 /
抑制剂/激动剂
药物研究
/
经典阳性药
小分子阳性药 蛋白酶
/
DPP4
糖尿病
/ Vildagliptin/维达列汀

Vildagliptin/维达列汀 {[allProObj[0].p_purity_real_show]}

货号：A403832 同义名： 维格列汀 / LAF237; NVP-LAF 237

Vildagliptin是一种 DPP-4 抑制剂，IC50 为 2.3 nM，常用于治疗 2 型糖尿病。

Vildagliptin/维达列汀 化学结构 CAS号：274901-16-5
Vildagliptin/维达列汀 化学结构
CAS号：274901-16-5
Vildagliptin/维达列汀 3D分子结构
CAS号：274901-16-5
Vildagliptin/维达列汀 化学结构 CAS号：274901-16-5
Vildagliptin/维达列汀 3D分子结构 CAS号：274901-16-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Vildagliptin/维达列汀 纯度/质量文件 产品仅供科研

货号：A403832 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
• Nat. Electron., 2025, 8, 66-74. Ambeed. [ A100095 ]
• Adv. Mater., 2025, 2416621. Ambeed. [ A255324 , A420052 ]
• Adv. Mater., 2025, 2410493. Ambeed. [ A838608 ]
• Adv. Mater., 2025, 2420319. Ambeed. [ A106129 ]
更多 >

Vildagliptin/维达列汀 生物活性

描述 Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It improves glycaemic control by inhibiting DPP-4 from inactivating the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, prolonging incretin activity in response to ingestion of nutrients. Vildagliptin also showed efficacy in reducing HbA(1c) levels in patients with type 2 diabetes when used in combination with metformin, pioglitazone or insulin. Vildagliptin was generally well tolerated when administered alone or in combination with additional antidiabetic treatment[3]. Oral vildagliptin is a useful option as monotherapy or as add-on therapy for patients with type 2 diabetes[4]. Inhibiting DPP-4 (dipeptidyl peptidase) signaling by vildagliptin could ameliorate pulmonary fibrosis by downregulating EndMT in systemic LPS-induced lung injury[5]. Vildagliptin (35 mg/kg; once daily by oral gavage) increases plasma active GLP-1 levels in islets of db/db mice[6]. Vildagliptin displayed protective capabilities against TNF-α-induced chondrocyte cell cycle arrest in the G1 phase. Moreover, vildagliptin suppresses the three major TNF-α-induced chondrocyte senescence proteins including p53, p21, and plasminogen activator inhibitor-1 (PAI-1). Vildagliptin also suppresses TNF-α-induced p53 acetylation at K382[7].

Vildagliptin/维达列汀 细胞研究

细胞系 浓度 检测类型 检测时间 活性说明 数据源
Caco-2 cells Function assay Inhibition of human DPP4 expressed in Caco-2 cells, Ki=0.004 μM 17034148
insect cells Function assay Inhibition of human recombinant His-tagged DPP4 expressed in insect cells, IC50=0.056 μM 20718420

Vildagliptin/维达列汀 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT01582308 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01582308 - Completed - -
NCT00099931 Diabetes Mellitus, Type 2 Phase 3 Completed - Germany ... 展开 >> Novartis Investigative Site Investigative Sites, Germany 收起 <<

Vildagliptin/维达列汀 参考文献

[1]Duttaroy A, Voelker F, et al. The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats. Eur J Pharmacol. 2011 Jan 15;650(2-3):703-7.

[2]Villhauer EB, Brinkman JA, et al. 1-[[(3-hydroxy-1-adamantyl)amino] acetyl] -2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J Med Chem. 2003 Jun 19;46(13):2774-89.

[3]Henness S, Keam SJ. Vildagliptin. Drugs. 2006;66(15):1989-2001; discussion 2002-4

[4]Keating GM. Vildagliptin: a review of its use in type 2 diabetes mellitus. Drugs. 2014 Apr;74(5):587-610

[5]Suzuki T, Tada Y, Gladson S, Nishimura R, Shimomura I, Karasawa S, Tatsumi K, West J. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respir Res. 2017 Oct 16;18(1):177

[6]Wu YJ, Guo X, Li CJ, Li DQ, Zhang J, Yang Y, Kong Y, Guo H, Liu DM, Chen LM. Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice. Metabolism. 2015 Feb;64(2):226-35

[7]Bi J, Cai W, Ma T, Deng A, Ma P, Han Y, Lou C, Wu L. Protective effect of vildagliptin on TNF-α-induced chondrocyte senescence. IUBMB Life. 2019 Jul;71(7):978-985

Vildagliptin/维达列汀 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.30mL

0.66mL

0.33mL

16.48mL

3.30mL

1.65mL

32.96mL

6.59mL

3.30mL

Vildagliptin/维达列汀 技术信息

CAS号274901-16-5
分子式C17H25N3O2
分子量 303.4
SMILES Code O[C@@]1(C2)C[C@H]3C[C@H](C[C@]2(NCC(N4[C@H](C#N)CCC4)=O)C3)C1
MDL No. MFCD08275142
别名 维格列汀 ;LAF237; NVP-LAF 237; Zomelis; DSP 7238
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C
溶解方案

H2O: 50 mg/mL(164.8 mM)，配合低频超声助溶

Tags: Vildagliptin | 274901-16-5 | LAF237 | NVP-LAF 237 | LAF 237 | LAF-237 | DPP-IV Inhibitor | Metabolic Enzyme/Protease | Apoptosis | Dipeptidyl Peptidase | Ferroptosis | Apoptosis | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Vildagliptin/维达列汀 纯度/质量文件 | Vildagliptin/维达列汀 生物活性 | Vildagliptin/维达列汀 细胞研究 | Vildagliptin/维达列汀 临床数据 | Vildagliptin/维达列汀 参考文献 | Vildagliptin/维达列汀 实验方案 | Vildagliptin/维达列汀 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z